John E. (Jack) Bailey Jr. G1 Therapeutics, Inc. (GTHX) insider trading activity

John E. (Jack) Bailey Jr. is President and CEO of G1 Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GTHX, which is worth approximately $0. The most recent transaction as insider was on Sep 18, 2024, when has been sold 534,787 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

John E. (Jack) Bailey Jr. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 18 2024	SELL Sale (or disposition) back to the issuer	-	534,787 Reduced 73.15%	196,287 Common Stock
Sep 18 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	196,287 Reduced 100.0%	0 Common Stock
Sep 18 2024	BUY Grant, award, or other acquisition	-	181,400 Added 19.88%	731,074 Common Stock
Jul 05 2024	SELL Open market or private sale	$19,231 $2.51 p/Share	7,662 Reduced 1.37%	549,674 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	105,000 Added 15.85%	557,336 Common Stock
May 13 2024	SELL Open market or private sale	$178,465 $4.79 p/Share	37,258 Reduced 7.61%	452,336 Common Stock
Jan 03 2024	SELL Open market or private sale	$36,460 $3.12 p/Share	11,686 Reduced 2.33%	489,594 Common Stock
Jan 03 2024	BUY Grant, award, or other acquisition	-	100,700 Added 16.73%	501,280 Common Stock
Jan 02 2024	SELL Open market or private sale	$107,854 $3.27 p/Share	32,983 Reduced 7.61%	400,580 Common Stock
Jul 05 2023	SELL Open market or private sale	$6,661 $2.45 p/Share	2,719 Reduced 0.62%	433,563 Common Stock
May 10 2023	BUY Grant, award, or other acquisition	-	160,000 Added 26.83%	436,282 Common Stock
Jan 04 2023	SELL Open market or private sale	$31,287 $5.58 p/Share	5,607 Reduced 1.99%	276,282 Common Stock
Jan 03 2023	SELL Open market or private sale	$187,311 $5.85 p/Share	32,019 Reduced 10.2%	281,889 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	80,700 Added 20.45%	313,908 Common Stock
Jan 03 2022	SELL Open market or private sale	$355,241 $10.41 p/Share	34,125 Reduced 12.76%	233,208 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	46,000 Added 14.68%	267,333 Common Stock
Jan 01 2021	BUY Grant, award, or other acquisition	-	213,333 Added 49.08%	221,333 Common Stock
Nov 11 2020	BUY Open market or private purchase	$51,320 $12.83 p/Share	4,000 Added 33.33%	8,000 Common Stock
Nov 10 2020	BUY Open market or private purchase	$51,040 $12.76 p/Share	4,000 Added 50.0%	4,000 Common Stock

JE(

John E. (Jack) Bailey Jr.

President and CEO

Research Triangle Park, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Value

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

Operation

Value

Type

News

Receive news related to G1 Therapeutics, Inc.

Track Activities on GTHX

Account